Ebola Cases May Be 10x Higher Than Reported, WHO Warns

By VirentaNews Staff — May 19, 2026

Emerging data and field reports suggest the current Ebola outbreak in central Africa may be significantly larger than official figures indicate, with World Health Organization (WHO) experts warning that the virus is likely spreading undetected across porous borders. While fewer than 300 confirmed cases have been reported across the Democratic Republic of the Congo (DRC), Uganda, and South Sudan, epidemiologists estimate the true number of infections could be tenfold higher due to weak surveillance, community mistrust, and inaccessible terrain. Without rapid scale-up of diagnostics, contact tracing, and cross-border coordination, experts fear a regional health crisis could escalate beyond containment capabilities in the coming months.

Surge in Suspected Cases Outpaces Lab Confirmation

As of late May 2024, the WHO has verified 287 Ebola cases in the eastern DRC, with 37 additional suspected cases in Uganda and South Sudan. However, Médecins Sans Frontières (MSF) teams on the ground report over 2,300 suspected cases in North Kivu and Ituri provinces alone—many exhibiting classic symptoms such as hemorrhagic fever, vomiting, and sudden organ failure. Only 35% of these cases have been tested due to limited mobile lab access and supply chain breakdowns. A recent WHO internal risk assessment, leaked to Reuters, estimates a case detection rate of just 12–18%, implying thousands may have been infected without formal diagnosis. In one health zone near Beni, 43 deaths were recorded in a single week, yet only 9 were confirmed Ebola-related due to insufficient PCR testing capacity.

Key Players: WHO, DRC Government, and Local Militias

The response is being led by the WHO in coordination with the DRC’s Ministry of Health, but efforts are being hampered by ongoing conflict involving over 120 armed groups in the eastern provinces. The M23 rebel movement now controls key transit routes, restricting access for health workers and vaccines. In February, an Ebola treatment center in Butembo was looted, delaying deployment of the rVSV-ZEBOV vaccine. Meanwhile, community resistance persists; in April, two contact tracers were attacked in Oicha after being mistaken for government spies. International partners, including CDC and MSF, have increased personnel but remain below operational thresholds. The African Union recently pledged $15 million in emergency funding, though disbursement has been slow. Crucially, regional cooperation with Uganda—which successfully contained a 2022 Sudan virus outbreak—has improved, with cross-border surveillance teams now sharing real-time data.

Trade-Offs: Speed vs. Accuracy, Security vs. Access

Health authorities face difficult trade-offs between rapid intervention and diagnostic rigor. Deploying vaccines and therapeutics without confirmation risks misallocating scarce resources, yet waiting for lab results delays life-saving care. The rVSV-ZEBOV vaccine, effective against the Zaire strain, is in limited global supply, with only 500,000 doses available through the WHO stockpile. Meanwhile, security concerns force agencies to limit field operations, reducing case detection but protecting staff. On the other hand, community-led surveillance programs—where local health workers use rapid antigen tests—have shown promise in increasing reporting rates by 60% in pilot zones. However, these lack regulatory approval for official case confirmation. Investments in mobile biosafety labs could bridge this gap, but require $8–10 million in immediate funding and secure transport routes.

Why Now: Conflict, Climate, and Complacency

The current surge coincides with a dramatic escalation in eastern DRC’s conflict, displacing over 6.9 million people—the highest in Africa—many into crowded camps with poor sanitation. This creates ideal conditions for viral spread. Additionally, heavy rains in early 2024 washed out rural roads, delaying response teams by days. But perhaps the greatest factor is global complacency. Since the 2014–2016 West Africa epidemic, funding for Ebola preparedness has declined by 44%, according to WHO data. The shift in global health focus to pandemic influenza and coronavirus variants has left hemorrhagic fever programs under-resourced. Now, with multiple outbreaks occurring simultaneously—including cholera in Haiti and mpox in Nigeria—the international response system is stretched thin.

Where We Go From Here

In the next six to twelve months, three scenarios are possible. In the best case, donor financing surges, security improves, and regional vaccination drives curb transmission by Q4 2024. A middle scenario sees localized containment but persistent hotspots due to continued instability, leading to 5,000–8,000 total infections. The worst-case scenario—uncontrolled spread into Rwanda, Burundi, or Tanzania—could result in over 20,000 cases and prompt a WHO-declared Public Health Emergency of International Concern (PHEIC). Success will depend on whether the international community treats this as a regional emergency rather than a national one. Real-time genomic sequencing, expanded use of rapid tests, and engagement with local leaders will be critical in all pathways.

Bottom line — without urgent investment in surveillance, security, and community trust, central Africa risks a catastrophic Ebola epidemic that could eclipse previous outbreaks in scale and lethality.

Source: BBC